Evidence map›Paper›PMID 40484947›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2025

Bi-regional and bi-phasic automated machine learning radiomics for defining metastasis to lesser curvature lymph node stations in gastric cancer.

Huilin Huang, Siwen Wang, Jingyu Deng, Zhaoxiang Ye, Hailin Li, Bingxi He, Mengjie Fang, Nannan Zhang, Jiaxin Liu, Di Dong and 4 more

Abstract read
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Huilin Huang *Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Siwen Wang *CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
Jingyu Deng *Department of Gastric Cancer Surgery, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, Tianjin, 300060, China.
Zhaoxiang Ye *Department of Radiology, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China.
Hailin LiBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Bingxi HeBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Mengjie FangCAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
Nannan ZhangState Key Laboratory of Cancer Biology and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 710000, Xi'an, China.
Jiaxin LiuDepartment of Radiology, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China.
Di DongCAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China. di.dong@ia.ac.cn.
Han LiangDepartment of Gastric Cancer Surgery, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, Tianjin, 300060, China. tjlianghan@126.com.
Guoxin LiDepartment of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. gzliguoxin@163.com.
Jie TianCAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China. jie.tian@ia.ac.cn.
Yanfeng HuDepartment of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. banby@smu.edu.cn.

Funding

Beijing Natural Science Foundation JQ24048, Z20J00105Clinical Research Program of Nanfang Hospital, Southern Medical University 2022CR002Guangdong Basic and Applied Basic Research Foundation 2022A1515220014; 2022A1515010462; 2021A1515011882Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Cancer 2020B121201004Guangzhou Basic and Applied Basic Research Foundation SL2022A04J02053Key-Area Research and Development Program of Guangdong Province 2021B0101420005National Key R&D Program of China 2023YFC241520National Natural Science Foundation of China 82272062, 82001948, 81971746, 82361168664, U24A20759, 82441018, 82372053, 82441017, 92259302, 82022036Science and Technology Development Fund of Macao Special Administrative Region 0006/2023/AFJScience and Technology projects in Guangzhou 2023B03J0277Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences CI2023C008YGStrategic Priority Research Program of Chinese Academy of Sciences XDB38040200the Guangdong Provincial Major Talents Project No.2019JC05Y361the Youth Innovation Promotion Association CAS 2021049
6 · The paper itself

Abstract

backgroundLymph node metastasis (LNM) is the primary metastatic mode in gastric cancer (GC), with frequent occurrences in lesser curvature. This study aims to establish a radiomic model to predict the metastatic status of lymph nodes in the lesser curvature for GC.

methodsWe retrospectively collected data from 939 gastric cancer patients who underwent gastrectomy and D2 lymphadenectomy across two centers. Both the primary lesion and the lesser curvature region were segmented as representative region of interests (ROIs). The combination of bi-regional and bi-phasic CT imaging features were used to build a hybrid radiomic model to predict LNM in the lesser curvature. And the model was validated internally and externally. Further, the potential generalization ability of the hybrid model was investigated in predicting the metastasis status in the supra-pancreatic area.

resultsThe hybrid model yielded substantially higher performance with AUCs of 0.847 (95% CI, 0.770-0.924) and 0.833 (95% CI, 0.800-0.867) in the two independent test cohorts, compared to the single regional and phasic models. Additionally, the hybrid model achieved AUCs ranging from 0.678 to 0.761 in the prediction of LNM in supra-pancreatic area, showing the potential generalization performance.

conclusionsThe CT imaging features of primary tumor and adjacent tissues are significantly associated with LNM. And our as-developed model showed great diagnostic performance and might be of great application in the individual treatment of GC.

Indexed as

Lymphatic MetastasisLymph NodesMachine LearningStomach NeoplasmsTomography, X-Ray ComputedAdultAgedFemaleGastrectomyHumansLymph Node ExcisionMaleMiddle AgedRadiomicsRetrospective StudiesLymphatic metastasisRadiomicsStomach neoplasmsTomography, X-Ray computed

Identifiers

PMID40484947
PMCPMC12147310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.